Otago's $50k TRG Grant is won with a pain management idea
|Associate Professor Natalie Medlicott (left) and Dr Ailsa McGregor. Photo: Sharron Bennett|
Dr Ailsa McGregor (Pharmacy) will work with Associate Professor Natalie Medlicott (Pharmacy) and Professor Paul Glue (Psychological Medicine), to develop a novel medication for severe pain that will increase pain control, prevent tolerance and reduce side effects.
The Translational Research Grant (TRG) is an initiative to assist researchers in the pursuit of research which translates into societal benefits, says Professor Ian Tucker (outgoing) Health Sciences Dean, research commercialisation.
Otago Innovation's Dr Alex Tickle is the commercialisation manager on this project, Dr Ailsa McGregor has the expertise in preclinical models, Associate Professor Natalie Medlicott has the expertise in formulations and pharmacokinetics and Professor Paul Glue has extensive experience with clinical studies.
For the full story about the research idea view the ODT story or Uni News Bulletin links below;
ODT story-Grant helps pain-relief research
"With New Zealand’s only dental school being at the University of Otago it should not be a surprise that Otago Innovation deals with a lot of dental projects, especially dental materials.
But Otago Innovation’s latest spin out company, Silventum, does not come from dentistry alone, but rather from a partnership between chemistry and dentistry. Specifically Dr Carla Meledandri’s nano-technology research team has partnered with dental clinician Dr Don Schwass. Their interest is in improving dental materials to treat caries. Silventum seeks to produce better forms of these compounds, perhaps to sell to existing dental materials companies or perhaps to make and market themselves.
As usual there is plenty that must remain confidential for now. But the company is up and running. It has an external investor, a board, a bunch of part time or very part time staff and a plan of action. Watch this space."